Sustained glutamate receptor activation down-regulates GABAB receptors by shifting the balance from recycling to lysosomal degradation.
Metabotropic GABA(B) receptors are abundantly expressed at glutamatergic synapses where they control excitability of the synapse. Here, we tested the hypothesis that glutamatergic neurotransmission may regulate GABA(B) receptors. We found that application of glutamate to cultured cortical neurons led to rapid down-regulation of GABA(B) receptors via lysosomal degradation. This effect was mimicked by selective activation of AMPA receptors and further accelerated by coactivation of group I metabotropic glutamate receptors. Inhibition of NMDA receptors, blockade of L-type Ca(2+) channels, and removal of extracellular Ca(2+) prevented glutamate-induced down-regulation of GABA(B) receptors, indicating that Ca(2+) influx plays a critical role. We further established that glutamate-induced down-regulation depends on the internalization of GABA(B) receptors. Glutamate did not affect the rate of GABA(B) receptor endocytosis but led to reduced recycling of the receptors back to the plasma membrane. Blockade of lysosomal activity rescued receptor recycling, indicating that glutamate redirects GABA(B) receptors from the recycling to the degradation pathway. In conclusion, the data indicate that sustained activation of AMPA receptors down-regulates GABA(B) receptors by sorting endocytosed GABA(B) receptors preferentially to lysosomes for degradation on the expense of recycling. This mechanism may relieve glutamatergic synapses from GABA(B) receptor-mediated inhibition resulting in increased synaptic excitability.
Maier
Patrick J
PJ
Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Marin
Isabel
I
Grampp
Thomas
T
Sommer
Andrea
A
Benke
Dietmar
D
D000818:Animals; D015153:Blotting, Western; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D020746:Calcium Channels, L-Type / Q000378:metabolism; D002478:Cells, Cultured; D015536:Down-Regulation; D004533:Egtazic Acid / Q000494:pharmacology; D004705:Endocytosis / Q000187:drug effects; D005971:Glutamates / Q000494:pharmacology; D007150:Immunohistochemistry; D017136:Ion Transport / Q000187:drug effects; D008247:Lysosomes / Q000378:metabolism*; D018613:Microscopy, Confocal; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009543:Nifedipine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D018091:Receptors, AMPA / Q000378:metabolism; D018080:Receptors, GABA-B / Q000378:metabolism*; D017470:Receptors, Glutamate / Q000378:metabolism*; D018094:Receptors, Metabotropic Glutamate / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / Q000494:pharmacology
D002121:Calcium Channel Blockers; D020746:Calcium Channels, L-Type; D005971:Glutamates; D018091:Receptors, AMPA; D018080:Receptors, GABA-B; D017470:Receptors, Glutamate; D018094:Receptors, Metabotropic Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; C104077:metabotropic glutamate receptor type 1; D004533:Egtazic Acid; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; D009543:Nifedipine; D002118:Calcium
J Biol Chem. 2007 Aug 17;282(33):24157-65
17581821
Neuroscience. 2005;136(4):1083-95
16226840
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6528-32
8393569
J Neurosci. 1991 Jan;11(1):203-9
1846009
Neuron. 2009 Mar 26;61(6):917-29
19324000
J Biol Chem. 2008 Sep 5;283(36):24641-8
18579521
J Biol Chem. 2008 Dec 12;283(50):34745-52
18812318
Nature. 2009 Mar 26;458(7237):445-52
19325624
Eur J Neurosci. 2000 Mar;12(3):803-9
10762309
J Biol Chem. 1999 Sep 17;274(38):27323-30
10480953
J Neurochem. 2008 Oct;107(1):86-95
18643869
Nat Cell Biol. 2007 Dec;9(12):1370-80
17994011
Cell Mol Life Sci. 2004 Mar;61(6):657-68
15052409
Neuropharmacology. 2009 Jun;56(8):1088-96
19328818
Physiol Rev. 2008 Oct;88(4):1407-47
18923186
J Neurosci. 2003 Dec 3;23(35):11026-35
14657159
Physiol Rev. 2009 Apr;89(2):411-52
19342611
Neuron. 1997 Jan;18(1):143-52
9010212
Annu Rev Pharmacol Toxicol. 2010;50:295-322
20055706
Mol Cell Neurosci. 2008 Dec;39(4):628-37
18948198
J Comp Neurol. 2004 Jun 28;474(3):340-52
15174078
J Recept Res. 1991;11(1-4):407-24
1653345
Physiol Rev. 2004 Jul;84(3):835-67
15269338
Neuron. 2006 May 18;50(4):589-601
16701209
Neuron. 2010 Apr 15;66(1):101-13
20399732
J Comp Neurol. 2004 Jul 12;475(1):36-46
15176083
J Neurosci. 2009 Feb 4;29(5):1414-23
19193888
J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):253-66
12503620
Neuron. 2000 Mar;25(3):673-81
10774734